Stay updated on Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial
Sign up to get notified when there's something new on the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page.

Latest updates to the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.3 was added to the history. The HHS Vulnerability Disclosure entry (Revision: v3.3.2) was removed.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page history now includes a new revision entry v3.3.2, and the previous revision v3.3.1 has been removed.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page history now shows a new revision identifier (v3.3.1) and the prior revision (v3.2.0) removed, indicating a backend/UI update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the generic government funding/operating status notice from the page header. The study record now displays without that disclaimer.SummaryDifference0.6%

- Check54 days agoChange DetectedThe Record History page includes a new version entry and minor layout adjustments, with no changes to core study content, status, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, with links to official status pages. - Updated version to v3.2.0; removed prior v3.1.0.SummaryDifference11%

Stay in the know with updates to Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page.